NCT00782847

Brief Summary

This study is designated to evaluate the effect of a patients' educational program called DiaNe® for consultation and support people with diabetic kidney disease in an early stage. The aim of the study is to examine if the program is suitable to stop deterioration of kidney function and to maintain or improve glycemic control. The consultation and support program DiaNe® substantially contributes to a better understanding of the affected clients for this complex clinical picture, allows them for specific interventions and creates the rationale for an active therapeutic relationship.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
125

participants targeted

Target at P25-P50 for phase_3

Timeline
Completed

Started Jul 2004

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

July 1, 2004

Completed
2.5 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

January 1, 2007

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

January 1, 2007

Completed
1.8 years until next milestone

First Submitted

Initial submission to the registry

October 30, 2008

Completed
1 day until next milestone

First Posted

Study publicly available on registry

October 31, 2008

Completed
Last Updated

October 31, 2008

Status Verified

October 1, 2008

Enrollment Period

2.5 years

First QC Date

October 30, 2008

Last Update Submit

October 30, 2008

Conditions

Keywords

diabetes mellitusdiabetic nephropathyhypertension

Outcome Measures

Primary Outcomes (1)

  • deterioration of kidney function in diabetic nephropathy

    13 months

Secondary Outcomes (1)

  • HbA1c

    13 months

Study Arms (2)

with DiaNe program

ACTIVE COMPARATOR

study subjects which participated in the DiaNe consultation and support program

Behavioral: DiaNe consultation and support program

without DiaNe program

NO INTERVENTION

study subjects which received standard care by diabetologist and/or nephrologist

Interventions

the DiaNe consultation and support program for clients with diabetic nephropathy consists of 4 sessions at 90-120 minutes conducted every week in a period of 4 weeks

Also known as: DiaNe program, DiaNe(R)
with DiaNe program

Eligibility Criteria

Age18 Years - 80 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • diabetes mellitus
  • proven diabetic nephropathy by histological/lab findings and/or discretion of nephrologist
  • ability to understand the German language

You may not qualify if:

  • end stage renal disease and/or dialysis
  • unable or unwilling to follow the protocol
  • pregnant women
  • discretion of nephrologist

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Diabetes- und Nierenzentrum Dormagen

Dormagen, North Rhine-Westphalia, D-41539, Germany

Location

Related Publications (1)

  • Cashmore BA, Cooper TE, Evangelidis NM, Green SC, Lopez-Vargas P, Tunnicliffe DJ. Education programmes for people with chronic kidney disease and diabetes. Cochrane Database Syst Rev. 2024 Aug 22;8(8):CD007374. doi: 10.1002/14651858.CD007374.pub3.

MeSH Terms

Conditions

Diabetic NephropathiesDiabetes MellitusHypertension

Condition Hierarchy (Ancestors)

Kidney DiseasesUrologic DiseasesFemale Urogenital DiseasesFemale Urogenital Diseases and Pregnancy ComplicationsUrogenital DiseasesMale Urogenital DiseasesDiabetes ComplicationsEndocrine System DiseasesGlucose Metabolism DisordersMetabolic DiseasesNutritional and Metabolic DiseasesVascular DiseasesCardiovascular Diseases

Study Officials

  • Ludwig F Merker, MD

    Diabetes- und Nierenzentrum Dormagen

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
phase 3
Allocation
RANDOMIZED
Masking
NONE
Purpose
SUPPORTIVE CARE
Intervention Model
PARALLEL
Sponsor Type
OTHER

Study Record Dates

First Submitted

October 30, 2008

First Posted

October 31, 2008

Study Start

July 1, 2004

Primary Completion

January 1, 2007

Study Completion

January 1, 2007

Last Updated

October 31, 2008

Record last verified: 2008-10

Locations